Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026
Facebook X (Twitter) Instagram
Trending
  • Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening
  • Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence
  • Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation
  • Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand
  • From the Mountains to the Sea: Captain Sanjay’s Initiative Opens New Career Opportunities for Himachal’s Daughters in the Merchant Navy
  • Shanti Educational Initiatives Wins BSE Clearance for Merger With Solar Powerhouse GREW Energy
  • How IH Global Helps Businesses Build Powerful Brand Experiences Through Exhibition Design, Trade Shows and Experiential Technology
  • How to Choose Furniture That Complements Your Lifestyle and Living Space
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Business»Thyrocare Technologies Limited reports revenue of INR 270.8 Cr in Q2 FY27, with a growth of 25.1% YoY
Business

Thyrocare Technologies Limited reports revenue of INR 270.8 Cr in Q2 FY27, with a growth of 25.1% YoY

Arjun SinghBy Arjun SinghOctober 29, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Thyrocare Reports Strong Q2FY27 Results – Revenue Up 25.1%, PAT before Exceptional Items Up 25.7%

Navi Mumbai (Maharashtra) [India], October 29: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, today announced its results for the quarter ended September 30, 2026. The Company delivered a robust performance in Q2FY27, with consolidated revenue of ₹270.8 crore, up 25.1% year-on-year, led by continued momentum in the Pathology segment, which grew 26.7% YoY. EBITDA rose 24.9% YoY to ₹89.3 crore. PAT before exceptional items surged 25.7% YoY to ₹60.2 crore, underscoring the Company’s focus on profitable growth.

Exceptional items comprise a one-time, non-cash impairment charge of ₹45 crore relating to NHL, recognised in the consolidated financial statements in connection with the definitive term sheet for the proposed sale of the NHL business. This charge has no impact on the Company’s operational performance. Thyrocare has issued a postal ballot seeking shareholders’ approval for the proposed divestment of its Nuclear Imaging business, enabling the Company to sharpen its focus and allocate capital towards its Pathology business, which offers a stronger growth trajectory, higher margins and better return on capital employed (ROCE).

Thyrocare, India’s largest diagnostic test volume processor, further strengthened its leadership position during the quarter, processing 61.6 million tests, up 27.4% year-on-year. The Pathology business maintained strong traction, with franchise revenue up 26.9% and partnership revenue up 27.9% year-on-year.

Thyrocare’s commitment to quality continued to deliver Six Sigma-level performance, with complaints reduced to 2.9 per million (down 24% YoY) and an average turnaround time (ATAT) of 3.49 hours from sample receipt.

Thyrocare continued its expansion into specialty diagnostics, marking the next phase of its growth journey. Having commenced with allergy and genomics, the Company is progressively expanding its specialty test portfolio, with a focus on building clinical trust through scientific rigour, uncompromising quality and industry-leading turnaround times.

Thyrocare also launched its Pregnancy Test Kit, a rapid home-testing solution that delivers results in just five minutes and is the first kit in India backed by a confirmatory lab test. The Company has onboarded actress Yami Gautam as brand ambassador to strengthen awareness and consumer outreach for this product. We have launched this with the help of our API Holdings group company Ascent and are already present in more than 10,000 chemists.

“Thyrocare reported a strong performance this quarter, driven by continued focus on operational efficiency, network expansion, and value-driven diagnostics. During the period, we also strengthened our specialty portfolio with the addition of allergy testing and entry into genomics through the launch of NIPT, with a phased expansion of the test menu underway. Thyrocare continues to expand its reach in underserved regions and scale its franchise and partner network, while remaining committed to delivering high-quality, affordable healthcare services across India. I am particularly excited about our foray into Point of Care devices with a unique proposition and soon hope to be present in all major chemist outlets.” – Rahul Guha, MD & CEO, Thyrocare Technologies Ltd.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Business
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand

November 20, 2026

How IH Global Helps Businesses Build Powerful Brand Experiences Through Exhibition Design, Trade Shows and Experiential Technology

November 20, 2026

How to Choose Furniture That Complements Your Lifestyle and Living Space

November 20, 2026

Comments are closed.

Top Posts

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
Lifestyle

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

By Arjun SinghNovember 20, 2026

New Delhi [India], November 20: Braces are no longer just for teenagers. Across Hyderabad, students,…

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026

Building ISAK Fragrances: From a 170 Year Family Legacy to a Modern Luxury Brand

November 20, 2026
Most Popular

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Invisalign by Dr. Swetha Reddy in Hyderabad Champions a “Diagnosis First” Approach as Gen Z Embraces Invisible Teeth Straightening

November 20, 2026

Three Shorty Awards. One Big Fight. Girl Effect’s India vs Tech Hinsa campaign brings Global Spotlight on online violence

November 20, 2026

Invisalign Relapse Correction by Hyderabad’s Trusted Orthodontist Dr. Kishor Gunnam Marks a Remarkable Smile Transformation

November 20, 2026

Type above and press Enter to search. Press Esc to cancel.